Catalog No.
Product Name
Application
Product Information
Citations
-
Drug Impurity
Glycopyrronium impurity 1, identified as 5-Nitroisophthalic acid, is an analytical reference standard utilized in quality control and method validation within pharmaceutical research. This compound serves as a significant impurity of Glycopyrronium, which is critical in ensuring the purity and safety of formulations containing this drug. Its presence can be monitored to assess the quality and consistency of glycopyrronium products, aiding in compliance with regulatory standards in drug development. -
Drug Impurity
Itraconazole impurity 14 is a recognized impurity of the antifungal agent itraconazole. This compound is essential for analytical and quality control applications in pharmaceutical research, facilitating the assessment of drug purity and stability. It is particularly relevant in studies involving the synthesis and formulation of itraconazole, ensuring compliance with regulatory standards for drug development. -
Drug Impurity
Moxifloxacin impurity 8 (N-Methyl moxifloxacin hydrochloride) is a known impurity of the antibiotic moxifloxacin. This compound is utilized primarily in analytical studies to assess the purity and quality of moxifloxacin formulations. It serves as an important reference standard in pharmaceutical research and development, ensuring adherence to regulatory guidelines during drug formulation and stability testing. -
Miglitol Impurity
rel-(3R,4S,5S)-1-(2-Hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol hydrochloride is identified as an impurity of Miglitol, a pharmaceutical agent used to manage type 2 diabetes. Its structural similarity to Miglitol provides insight into the compound's metabolism and safety profile in drug development. This reagent is valuable for analytical chemistry, allowing for the assessment of purity and identification of potential by-products in the synthesis of Miglitol. -
Drug Impurity
Trazodone impurity 6 is a detected impurity associated with the antidepressant Trazodone. It is essential for evaluating the purity of Trazodone formulations and is useful in pharmaceutical quality control studies. Analysis of this impurity can help ensure compliance with regulatory standards and support research applications in drug development and formulation stability. -
Drug Impurity
Acebutolol impurity 6 is a characterized chemical impurity of the antihypertensive agent Acebutolol. This compound serves as an important reference standard for the identification and quantification of impurities during the drug development process. It is utilized in analytical studies to ensure the quality and compliance of pharmaceutical formulations containing Acebutolol. -
Drug Impurity
Gabapentin acid impurity 3 hydrochloride is a known impurity of Gabapentin acid hydrochloride. This compound serves as a crucial reference standard for quality control and analytical validation in pharmaceutical research. It aids in the assessment of the purity and stability of Gabapentin formulations, contributing to the overall understanding of drug development processes and regulatory compliance. -
Drug Impurity
5-Nitrobenzofuran-2-carboxylic acid is characterized as a drug impurity that may occur in various pharmaceutical formulations. Its presence can impact drug efficacy and stability, making it an important compound to study in drug development and quality control processes. Research involving this compound is crucial for understanding its effects on drug formulation and potential toxicity. -
Drug Impurity
Apremilast impurity 66 is a drug impurity associated with Apremilast, a selective inhibitor of phosphodiesterase 4 (PDE4). This compound serves as an important reference standard for assessing the quality and purity of Apremilast in pharmaceutical formulations. Research applications include stability studies, method validation, and the assessment of synthetic processes in drug development. -
Drug Intermediate
2-Chloroethyl (2-chloroethyl)phosphonate is an organophosphorus compound primarily utilized as a drug intermediate in organic synthesis. Its structure facilitates the formation of phosphonate derivatives, making it a valuable reagent in the development of various bioactive molecules. This compound is essential for researchers engaged in synthetic chemistry and pharmaceutical research aimed at discovering new therapeutic agents. -
Drug Impurity
Ticagrelor impurity 89 is a recognized impurity associated with the antiplatelet agent Ticagrelor, primarily impacting its pharmacological profile. This compound is essential for quality control and analytical studies within pharmaceutical development. It aids in assessing the purity and stability of Ticagrelor formulations, enhancing research into its efficacy and safety in clinical applications. -
Drug Impurity
Clindamycin phosphate impurity 5 is a chemical impurity associated with Clindamycin phosphate. This compound is critical for regulatory compliance and analytical studies related to the quality control of Clindamycin formulations. It may aid in the assessment of drug purity and the identification of potential degradation products in pharmaceutical research. -
Drug Impurity
Roflumilast impurity 1, also known as 3,4-Di(cyclopropylmethoxy) roflumilast, is an impurity associated with the pharmaceutical compound Roflumilast. This substance is relevant for analytical studies and quality control in the synthesis of Roflumilast, serving as an important reference material in drug development and validation processes. Its identification and quantification are critical for ensuring the purity and safety of pharmaceutical formulations. -
Drug Impurity
Levofloxacin Impurity 17 is a known impurity associated with the antibiotic levofloxacin. This compound is utilized in pharmaceutical research to assess the quality and purity of levofloxacin formulations. It is crucial for studying the synthesis, stability, and degradation pathways of levofloxacin, contributing to the development of safe and effective drug products. -
Drug Impurity
Linagliptin impurity 2, also known as Linagliptin acetamide, is a structural impurity associated with Linagliptin, an oral antihyperglycemic agent. This compound is primarily utilized in quality control and analytical applications to ensure the purity of Linagliptin formulations. Its identification and quantification are vital for regulatory compliance and to assess the compound's stability and safety profiles in pharmaceutical development. -
Drug Impurity
Ibuprofen impurity 3, also known as Ibuprofen EP impurity H, is a chemical impurity associated with the pharmaceutical compound Ibuprofen. This reagent is crucial for quality control and compliance testing in the development and manufacturing of Ibuprofen formulations. It is utilized in research to evaluate the purity and safety profiles of Ibuprofen, ensuring adherence to regulatory standards in pharmaceutical analysis. -
Drug Impurity
Glipizide impurity 3, also known as Glipizide impurity D, is a chemical impurity associated with Glipizide, a medication primarily used to manage type 2 diabetes. Characterizing this impurity is crucial for ensuring the quality and safety of pharmaceutical formulations. Its analysis plays a vital role in regulatory compliance and can provide insights into the stability and efficacy of Glipizide-containing products. -
Drug Impurity
Tenofovir impurity 8 fumarate is a known impurity associated with Tenofovir fumarate, an antiviral agent primarily targeting HIV. This compound serves as a critical reference standard in analytical chemistry and quality control for pharmaceutical formulation and development, ensuring the purity and efficacy of Tenofovir-based medications. Its identification and quantification are essential for compliance with regulatory standards in drug manufacturing. -
Drug Impurity
Lincomycin impurity 2, also known as Methyl 1-thiolincosaminide, serves as a drug impurity associated with Lincomycin. This compound can play a significant role in the assessment of pharmaceutical formulations, particularly in quality control studies and stability testing. Researchers investigating the pharmacokinetics and metabolic pathways of lincomycin may employ this impurity for comprehensive analytical evaluations. -
Drug Impurity
Estradiol Valerate impurity 3 is a chemical impurity associated with Estradiol Valerate. This compound is significant for analytical purposes in ensuring the quality and purity of estradiol-based formulations. It plays a critical role in the study of pharmacokinetics and drug metabolism, aiding researchers in developing safer and more effective therapeutic options. -
Drug Intermediate
(R)-(4-Bromophenyl)(phenyl)methanamine is a synthetic intermediate widely utilized in organic synthesis. Its unique structure allows for the development of various pharmaceutical compounds, contributing to research in medicinal chemistry. This reagent plays a crucial role in the modification of molecular architectures, facilitating investigations into their biological activities and therapeutic potentials. -
Drug Impurity
Beclometasone dipropionate impurity 1, also known as Beclomethasone 21-acetate 17-propionate, serves as a drug impurity. It can be utilized in the analysis of Beclometasone dipropionate formulations, aiding in the assessment of purity and quality control processes. This compound is essential for researchers studying drug efficacy and safety profiles in pharmaceutical development. -
Drug Impurity
Pantoprazole Impurity 1 is a characterized impurity associated with the proton pump inhibitor Pantoprazole. Its presence in formulations can be crucial for quality control and regulatory compliance in pharmaceutical development. Researchers can utilize this impurity to study the stability, degradation pathways, and overall safety profiles of Pantoprazole and related compounds. This reagent aids in ensuring the integrity and efficacy of pharmaceutical products containing Pantoprazole. -
Drug Impurity
Paliperidone impurity 1 is a pharmaceutical impurity associated with Paliperidone, an atypical antipsychotic. It serves as a critical reference standard for the analysis, identification, and characterization of drug substances and formulations. This impurity is essential for ensuring the quality and compliance of pharmaceutical products within the analytical and regulatory environments of drug development. -
Drug Impurity
Brimonidine impurity 6 is a chemical entity that serves as an impurity in the pharmaceutical compound Brimonidine. It is primarily utilized in analytical chemistry for the characterization and quality control of Brimonidine formulations. This impurity can aid in understanding the structural integrity and stability of drug products, ensuring compliance with regulatory standards in pharmaceutical development. -
Drug Impurity
Salbutamol impurity 7 is a known impurity of the bronchodilator Salbutamol, which primarily targets beta-2 adrenergic receptors. This compound is important for analytical research and quality control in pharmaceutical development to ensure the purity and safety of Salbutamol formulations. Its presence can influence pharmacokinetics and therapeutic efficacy, making it relevant for studies focused on drug metabolism and impurities. -
Drug Impurity
Hydrocortisone impurity 5, also known as 6-Dehydrocortisol, is a known impurity of hydrocortisone. This compound is primarily used in the evaluation of drug purity and stability. Its presence can be critical for analytical methods in pharmaceutical research, ensuring the integrity of steroid formulations. Additionally, it serves as a reference standard in the development of quality control tests for hydrocortisone-based products. -
Drug Impurity
Quetiapine impurity 7 is an identified impurity of the atypical antipsychotic quetiapine, which acts primarily as a serotonin (5-HT) and dopamine (D2) receptor antagonist. This compound is essential for purity assessment in drug development and quality control processes, aiding in the identification and quantification of impurities in pharmaceutical formulations. Its study contributes to the understanding of quetiapine's overall safety and efficacy profile in clinical use. -
Drug Intermediate
3-Amino benzamidoxime, also known as 3-amino-N'-hydroxybenzene-1-carboximidamide, is a synthetic intermediate primarily utilized in pharmaceutical synthesis. Its chemical structure facilitates the formation of various active pharmaceutical ingredients, making it a valuable reagent in drug development. Researchers leverage this compound for its role in optimizing synthetic pathways and enhancing the yield of biologically active molecules. -
Drug Impurity
Lopinavir impurity 5 is a known impurity of the antiretroviral drug Lopinavir, primarily associated with the manufacturing process. As a chemical research reagent, it serves as a critical component for quality control and stability assessments in pharmaceutical formulations. Its identification and quantification are essential for ensuring the purity and efficacy of Lopinavir in therapeutic applications by supporting compliance with regulatory standards. -
Sunset Yellow FCF Impurity
Disodium 6,6′-oxybis(2-naphthalenesulfonate) is an impurity of Sunset Yellow FCF that functions primarily as a surfactant, emulsifier, and dispersant. This compound exhibits significant potential in enhancing the solubility and stability of formulations. It is utilized in the synthesis of polymers, pharmaceuticals, and agrochemicals, making it a valuable reagent for various chemical research applications. -
Drug Impurity
Tenofovir impurity 10 is a known impurity of the antiretroviral agent Tenofovir, primarily utilized in the study of drug formulations and quality control processes. This compound serves as a critical reference standard in pharmaceutical research, specifically for the detection and quantification of Tenofovir impurities during manufacturing. Its analysis plays an essential role in ensuring the safety and efficacy of Tenofovir-based therapies. -
Drug Impurity
Levothyroxine Impurity 5 is a counter ion impurity associated with Levothyroxine, primarily identified in the analytical characterization of this thyroid hormone. Its chemical profile is crucial for ensuring the quality and safety of Levothyroxine formulations in pharmaceutical research. This reagent can be utilized in stability studies, quality control, and method development to evaluate the purity of Levothyroxine and its formulations. -
Drug Impurity
Cabozantinib impurity 8 is a drug impurity related to the tyrosine kinase inhibitor cabozantinib, which primarily targets MET and VEGFR pathways. This compound serves as an important reference standard for analytical applications, particularly in the quality control and characterization of cabozantinib formulations. Its presence in pharmacological assessments aids in understanding the effects and safety profiles of cabozantinib derivatives in drug development. -
Voriconazole Impurity
10-Camphorsulfonic acid ethyl ester is recognized as a Voriconazole impurity. This compound serves as a valuable reference material for the analysis of Voriconazole in pharmaceutical research. It is utilized to study the synthesis pathways and to assess the purity of Voriconazole in various formulations. -
Drug Impurity
Haloperidol impurity 3, also known as 3-Ethyl haloperidol, is a synthetic impurity associated with the antipsychotic drug Haloperidol. This chemical can be used in method development and validation for pharmaceutical analysis and quality control. Its presence in drug formulations can impact biological activity and pharmacokinetics, making its study relevant for drug safety and efficacy assessments. -
Drug Intermediate
2-Methyl benzamideoxime is a synthetic intermediate primarily utilized in pharmaceutical synthesis. It serves as a versatile building block in the development of diverse drug compounds, facilitating modifications that enhance biological activity. Its application in the preparation of complex molecules makes it a valuable reagent in chemical research and drug development. -
Drug Impurity
Telmisartan impurity 17 is a known impurity associated with the angiotensin II receptor antagonist Telmisartan. This compound is important for analytical and quality control applications, as it aids in the assessment of drug purity and stability during formulation development. It serves as a critical reference standard in the evaluation of chromatographic techniques and contributes to the regulatory compliance of pharmaceutical products. -
Drug Impurity
Rivaroxaban impurity 18 is a drug impurity associated with Rivaroxaban, an anticoagulant that inhibits Factor Xa. This compound serves as an important reference for analytical methods in quality control and compliance testing of Rivaroxaban formulations. It is essential for researchers investigating the safety and efficacy profiles of anticoagulant therapies. -
Drug Impurity
Diclofenac impurity 1 is a known impurity of the nonsteroidal anti-inflammatory drug Diclofenac. It is utilized primarily in pharmaceutical research to assess the purity and quality of Diclofenac formulations. This compound serves as a reference material for analytical methods, including HPLC and mass spectrometry, enabling the identification and quantification of impurities in drug products. -
Drug Impurity
Quetiapine impurity 20 is a chemical impurity associated with the antipsychotic agent Quetiapine. It serves as an important reference standard for assessing the purity of pharmaceutical formulations containing Quetiapine. This reagent is essential for stability studies, quality control, and regulatory compliance in drug development and manufacturing processes. -
Drug Impurity
Hydrocortisone acetate impurity 1 is a chemical compound identified as an impurity of hydrocortisone acetate. This reagent is essential for quality control and analytical applications in pharmaceutical research, particularly in the development and assessment of corticosteroid formulations. Its presence must be monitored to ensure drug purity and efficacy, making it a critical component in the study of hydrocortisone acetate-based therapies. -
Drug Impurity
Cinacalcet impurity 10 is a known impurity of the drug Cinacalcet. This compound is significant for quality control and analytical purposes in pharmacological research. Its characterization is essential for ensuring the purity and compliance of Cinacalcet in various formulations, supporting studies on drug efficacy and safety. -
Drug Impurity
Rosuvastatin impurity 53 is a chemical impurity associated with Rosuvastatin, a statin used to lower cholesterol levels. Its characterization is essential for ensuring the purity and quality of Rosuvastatin formulations in pharmaceutical research and development. This impurity serves as a reference standard for analytical methods, enabling accurate detection and quantification in drug formulation analysis. -
Drug Impurity
Azilsartan impurity 1 is a known impurity of the antihypertensive drug Azilsartan, which primarily targets the angiotensin II receptor. This compound is used in research to assess the purity of Azilsartan formulations and to understand the drug’s stability and safety profile. Analysis of this impurity is crucial for regulatory compliance and quality control in pharmaceutical development. -
Drug Intermediate
GS-1427 intermediate-2 is a crucial chemical intermediate involved in the synthesis of GS-1427, a potent therapeutic agent. This compound serves as an essential building block in the development of novel pharmaceuticals, facilitating research into targeted therapies. Its role in the synthetic pathway underscores its importance in drug discovery and optimization processes. -
Drug Impurity
Ciprofloxacin impurity 6 is a known impurity associated with the antibiotic ciprofloxacin. It is primarily utilized in drug formulation and quality control to ensure the purity and safety of pharmaceutical products. This compound is important for assessing the stability and degradation pathways of ciprofloxacin and may serve as a reference standard in analytical methods. Researchers studying ciprofloxacin can leverage this impurity to better understand the compound's effects and potential interactions. -
Drug Impurity
Empagliflozin impurity 108 is a known impurity of the SGLT2 inhibitor Empagliflozin. This compound is utilized primarily in the evaluation of drug purity and stability in pharmaceutical development. Its identification and characterization are crucial for ensuring the quality and compliance of Empagliflozin formulations in research and regulatory settings. -
Ibuprofen Impurity
m-Isobutyl Ibuprofen is an impurity associated with the synthesis of Ibuprofen. This compound serves as a critical reference standard for analytical chemistry, particularly in the quality control of Ibuprofen formulations. Its biological activity may include modulation of COX enzyme pathways, making it relevant in pharmacokinetic studies and the evaluation of Ibuprofen's therapeutic profile. m-Isobutyl Ibuprofen is essential for researchers focusing on pharmaceutical development and impurity profiling. -
Amikacin Impurity
Amikacin impurity 2, also referred to as compound Impurity VI, is a recognized impurity associated with Amikacin. This compound is identified within Amikacin sulfate and is pertinent for studies focused on the characterization and quality control of antibiotic formulations. Research applications include assessing impurity profiles and evaluating the stability and efficacy of Amikacin-based therapies.
